DEAR MAYO CLINIC: A friend recently went through a bout of shingles. I really don't know much about this condition, but I know it was painful. How do you get it? Is there a treatment or vaccine for it?
Nov 29, 2022
0
5
Peter Gulick, a professor in the Michigan State University College of Osteopathic Medicine, has been studying HIV/AIDS since the epidemic began in the early 1980s.
Nov 29, 2022
0
3
More than half of all women in the United States are overweight or obese when they become pregnant. While being or becoming overweight during pregnancy can have potential health risks for moms, there are also hints that it ...
Nov 28, 2022
0
36
In a world first, scientists at Duke-NUS Medical School and colleagues in Singapore have sequenced the response to viral infection in colony-bred cave nectar bats (Eonycteris spelaea) at single-cell resolution. Published ...
Nov 23, 2022
1
63
The World Health Organization and the U.S. Centers for Disease Control and Prevention say measles immunization has dropped significantly since the coronavirus pandemic began, resulting in a record high of nearly 40 million ...
Nov 23, 2022
0
3
Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant. A new study led by Katrine Finderup ...
Nov 22, 2022
0
41
Two new studies from researchers at Fred Hutchinson Cancer Center in Seattle reveal how bacteria infiltrate tumors and could be helping tumors progress and spread. The research team also showed that the different microbial ...
Nov 16, 2022
0
57
In late October, the UK Health Security Agency assigned variant designations to two new omicron "grandchildren": BQ.1 and XBB. This means they will be monitored by health authorities, but are not at this stage regarded as ...
Nov 14, 2022
0
3
In England, the current pandemic strategy relies on vaccine protection to minimize the impacts of COVID infections. But vaccine uptake is not as good as it could be. As of October 23 2022, although 80% of adults had received ...
Nov 8, 2022
0
5
Research in Africa found a one-time dose of an experimental drug protected adults against malaria for at least six months, the latest approach in the fight against the mosquito-borne disease.
Nov 5, 2022
0
20
